Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

Brock University

$69,000.00

Monoterpenoid indole alkaloid biosynthesis

FY 2022-23

Summary
Plantshave remarkable attributes for being able to perform complex and biologicallyinnovative biochemistry that generates a diversity of colors, fragrances, aromasand biologically active organic molecules. While the majority of the molecules produced arenot directly essential for survival, many may play key roles in plantadaptation to the biotic and abiotic environment. The unique biologicalactivities of this chemical diversity have provided medicinal and diseasepreventing molecules that have been used by humanity to prevent/cure manydevastating diseases. The monoterpenoid indole alkaloids (MIAs) makeup the largest and most diverse class of compounds that are characteristicallyfound within many members of the Apocynaceae (4700 species), the Loganiaceae(600 species) and the Rubiaceae (> 10,000 species) plant families. Thecomplexity of MIA chemistry is matched by their remarkably diverse effects onliving organisms that has led to their use as drugs for preventing malaria(quinine) and for treating neurological disorders (reserpine), cancer(camptothecin, vinblastine and vincristine), as vasodilators (yohimbine), asanti-inflammatories for gout treatments (colchicine) and as potential analgesics and novel painkillers (conolidine) in human beings. Over the past >25 years my laboratoryhas made many key discoveries about the biosynthesis ofanti-cancer MIAs of the Madagascar periwinkle (Catharanthus roseus) that have been used in chemotherapy treatmentsover the past 45 years. The genetic resources and biochemical knowledge derived from these discoveries arepresently being exploited to enhance the production of valuable medicinalcompounds in C. roseus or through synthetic biology experiments in other organisms including yeast or in microbialfactories. The production of MIA pharmaceuticals in recombinant organismscreates unique opportunities for less expensive manufacturing of existing MIA drugsand for generating new and unique medicines not available from natural sources. The initial discoveries made in this model plant have also greatly improved the tools available for gene discovery of other MIA pathways found in Nature and for learning about the ecological roles that MIAs play in plant fitness and adaptations to their environment.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2017-04145
Name nom
De Luca, Vincenzo
Department département
Biological Sciences - Biological Sciences
Organization id
22
Institution établissement
Brock University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2017
Award amount
69000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5400
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Biochemistry
Research subject fr
Biochimie
Installment
inst:6
Partie
1
Nb partie
6
Application title
Monoterpenoid indole alkaloid biosynthesis
Application summary
Plantshave remarkable attributes for being able to perform complex and biologicallyinnovative biochemistry that generates a diversity of colors, fragrances, aromasand biologically active organic molecules. While the majority of the molecules produced arenot directly essential for survival, many may play key roles in plantadaptation to the biotic and abiotic environment. The unique biologicalactivities of this chemical diversity have provided medicinal and diseasepreventing molecules that have been used by humanity to prevent/cure manydevastating diseases. The monoterpenoid indole alkaloids (MIAs) makeup the largest and most diverse class of compounds that are characteristicallyfound within many members of the Apocynaceae (4700 species), the Loganiaceae(600 species) and the Rubiaceae (> 10,000 species) plant families. Thecomplexity of MIA chemistry is matched by their remarkably diverse effects onliving organisms that has led to their use as drugs for preventing malaria(quinine) and for treating neurological disorders (reserpine), cancer(camptothecin, vinblastine and vincristine), as vasodilators (yohimbine), asanti-inflammatories for gout treatments (colchicine) and as potential analgesics and novel painkillers (conolidine) in human beings. Over the past >25 years my laboratoryhas made many key discoveries about the biosynthesis ofanti-cancer MIAs of the Madagascar periwinkle (Catharanthus roseus) that have been used in chemotherapy treatmentsover the past 45 years. The genetic resources and biochemical knowledge derived from these discoveries arepresently being exploited to enhance the production of valuable medicinalcompounds in C. roseus or through synthetic biology experiments in other organisms including yeast or in microbialfactories. The production of MIA pharmaceuticals in recombinant organismscreates unique opportunities for less expensive manufacturing of existing MIA drugsand for generating new and unique medicines not available from natural sources. The initial discoveries made in this model plant have also greatly improved the tools available for gene discovery of other MIA pathways found in Nature and for learning about the ecological roles that MIAs play in plant fitness and adaptations to their environment.
Brock University - $69,000 Grant (2022-23) | Canada Spends